Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference01:23

RNA Interference

26.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.2K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

3.6K
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026
Same author

Lewis Acidic Bentonite Clays as Catalysts for 5' Deprotection of Nucleosides and Dinucleotides.

Organic letters·2026
Same author

Publisher Correction: Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.

Nature chemistry·2026
Same author

Unlocking chemical diversity in aptamers with DNA orthogonal barcodes.

Nature chemistry·2026
Same author

Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides.

Nucleic acids research·2026
Same author

A nanopore-based HIV-1 reference epitranscriptome.

Nucleic acids research·2026

Related Experiment Video

Updated: Jul 30, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K

Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake.

Sepideh Kaviani1, Hassan H Fakih1, Jathavan Asohan1

  • 1Department of Chemistry, McGill University, Montreal, Canada.

Nucleic Acid Therapeutics
|May 17, 2023
PubMed
Summary

Optimizing hydrophobic polymer sequences in spherical nucleic acids (SNAs) significantly enhances the delivery and gene silencing capabilities of antisense oligonucleotides (ASOs). This research details how polymer architecture impacts SNA performance for improved therapeutic applications.

Keywords:
DNA nanostructuresdeliverygene silencingsequence-controlled polymerssmall-molecule encapsulationspherical nucleic acids

More Related Videos

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

7.4K
Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

10.7K

Related Experiment Videos

Last Updated: Jul 30, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K
Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

7.4K
Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

10.7K

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Molecular Biology

Background:

  • Antisense oligonucleotides (ASOs) face challenges in delivery, cellular uptake, and endosomal escape, limiting their clinical translation.
  • Spherical nucleic acids (SNAs), nanoparticles with a DNA shell and hydrophobic core, show promise for enhancing ASO efficacy.
  • The influence of the hydrophobic polymer sequence on SNA biological properties remains largely unexplored.

Purpose of the Study:

  • To investigate the impact of hydrophobic polymer sequence and composition on SNA properties.
  • To identify optimized polymer architectures for improved gene silencing using SNAs.

Main Methods:

  • Created a library of ASO-polymer conjugates using linear or branched [dodecanediol phosphate] units.
  • Systematically varied polymer sequence and composition.
  • Evaluated encapsulation efficiency, gene silencing activity, SNA stability, and cellular uptake.

Main Results:

  • Hydrophobic polymer sequence and composition significantly affect SNA encapsulation efficiency.
  • Optimized polymer architectures led to enhanced gene silencing activity.
  • SNA stability and cellular uptake were demonstrably improved by specific polymer designs.

Conclusions:

  • The sequence and architecture of hydrophobic polymers are critical determinants of SNA performance.
  • Tailoring polymer composition offers a viable strategy to optimize SNAs for enhanced ASO delivery and gene silencing.
  • This study provides a foundation for designing next-generation SNAs for therapeutic applications.